Redicare Cough Drops Cherry Flavored

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with colds or inhaled irritants, specifically cough and sore throat.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 5 years and older, the recommended dosage is one drop to be allowed to dissolve slowly in the mouth. This dosage may be repeated every hour as necessary or as directed by a healthcare practitioner.

For children under 5 years of age, it is advised to consult a healthcare practitioner prior to use to determine appropriate dosing and administration.

Contraindications

Use is contraindicated in patients who experience a cough that persists for more than one week, tends to recur, or is accompanied by fever, rash, or persistent headache. Additionally, use should be discontinued and a healthcare professional consulted if a sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this medication.

Patients should be advised to consult a physician prior to use if they have a persistent or chronic cough, particularly if it is associated with smoking, asthma, or emphysema. Additionally, individuals experiencing a cough accompanied by excessive phlegm (mucus) should seek medical advice before initiating treatment.

It is imperative to discontinue use and consult a healthcare provider if the cough persists for more than one week, recurs frequently, or is accompanied by symptoms such as fever, rash, or a persistent headache. Furthermore, patients should be instructed to seek medical attention if they experience a severe sore throat that lasts longer than two days, especially if it is accompanied by fever, headache, rash, swelling, nausea, or vomiting.

For general precautions, it is recommended that pregnant or breastfeeding individuals consult a healthcare professional prior to use. Additionally, all medications should be stored out of reach of children to prevent accidental ingestion.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious adverse reactions may occur, and it is advised that patients consult a healthcare professional before use if they have a persistent or chronic cough, such as that which occurs with smoking, asthma, or emphysema. Additionally, patients with a cough accompanied by excessive phlegm (mucus) should seek medical advice prior to use.

Patients are instructed to discontinue use and consult a healthcare provider if the cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. Furthermore, if a sore throat is severe, lasts for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, patients should stop using the medication and seek medical attention.

These warnings are critical for ensuring patient safety and should be heeded to avoid potential complications.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Redicare Cough Drops Cherry Flavored (cherry flavored menthol cough drops). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 5 years and older may use the medication by allowing 1 drop to dissolve slowly in the mouth, with the option to repeat every hour as necessary or as directed by a healthcare practitioner. For children under 5 years of age, it is advised to consult a healthcare practitioner prior to use to ensure safety and appropriate dosing.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects, non-teratogenic effects, or any specific findings in the nonclinical toxicology section. Additionally, no data has been provided concerning animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of reach of children to prevent accidental ingestion.

Patients should be instructed to stop using the medication and consult a doctor if their cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. Additionally, if a sore throat is severe, lasts for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, patients should seek medical advice.

It is also important for healthcare providers to remind patients to consult a doctor before using this medication if they have a persistent or chronic cough, such as that which occurs with smoking, asthma, or emphysema. Patients should be advised to seek medical guidance if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at room temperature, ensuring that it is protected from moisture and heat to maintain its integrity and efficacy. Proper storage conditions are essential for optimal product performance.

Additional Clinical Information

The medication is administered orally, with a recommended dosage of one drop allowed to dissolve slowly in the mouth for adults and children aged 5 years and older. This dosage may be repeated every hour as necessary or as directed by a healthcare practitioner. For children under 5 years of age, consultation with a healthcare practitioner is advised prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Redicare Cough Drops Cherry Flavored, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)